| Year |
Citation |
Score |
| 2021 |
Petrash JM, Shieh B, Ammar DA, Pedler MG, Orlicky DJ. Diabetes-Independent Retinal Phenotypes in an Aldose Reductase Transgenic Mouse Model. Metabolites. 11. PMID 34357344 DOI: 10.3390/metabo11070450 |
0.325 |
|
| 2019 |
Zukin LM, Pedler MG, Chyung K, Seiwald S, Lenhart P, Shieh B, Petrash JM. Aldose reductase inhibition enhances lens regeneration in mice. Chemico-Biological Interactions. PMID 31026421 DOI: 10.1016/J.Cbi.2019.04.021 |
0.37 |
|
| 2019 |
Chang KC, Shieh B, Petrash JM. Role of aldose reductase in diabetes-induced retinal microglia activation. Chemico-Biological Interactions. PMID 30682331 DOI: 10.1016/J.Cbi.2019.01.020 |
0.712 |
|
| 2019 |
Zukin LM, Pedler MG, Groman-Lupa S, Pantcheva M, Ammar DA, Petrash JM. Aldose Reductase Inhibition Prevents Development of Posterior Capsular Opacification in an In Vivo Model of Cataract Surgery. Investigative Ophthalmology & Visual Science. 59: 3591-3598. PMID 30025084 DOI: 10.1167/Iovs.18-23935 |
0.329 |
|
| 2018 |
Chang KC, Petrash JM. Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease. Advances in Experimental Medicine and Biology. 1032: 173-202. PMID 30362099 DOI: 10.1007/978-3-319-98788-0_13 |
0.697 |
|
| 2018 |
Zhang C, Lai MB, Pedler MG, Johnson V, Adams RH, Petrash JM, Chen Z, Junge HJ. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 2691-2705. PMID 30354230 DOI: 10.1161/Atvbaha.118.311689 |
0.342 |
|
| 2018 |
Kalita D, Holm DG, LaBarbera DV, Petrash JM, Jayanty SS. Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds. Plos One. 13: e0191025. PMID 29370193 DOI: 10.1371/Journal.Pone.0191025 |
0.365 |
|
| 2017 |
Chang KC, Shieh B, Petrash JM. Influence of aldose reductase on epithelial-to-mesenchymal transition signaling in lens epithelial cells. Chemico-Biological Interactions. PMID 28137510 DOI: 10.1016/J.Cbi.2017.01.017 |
0.688 |
|
| 2016 |
Chang KC, Li L, Sanborn TM, Shieh B, Lenhart P, Ammar D, LaBarbera DV, Petrash JM. Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract. Journal of Natural Products. PMID 27140653 DOI: 10.1021/Acs.Jnatprod.6B00185 |
0.701 |
|
| 2016 |
Chang KC, Shieh B, Petrash JM. Aldose Reductase Mediates Retinal Microglia Activation. Biochemical and Biophysical Research Communications. PMID 27033597 DOI: 10.1016/J.Bbrc.2016.03.122 |
0.695 |
|
| 2015 |
Mueller NH, Fogueri U, Pedler MG, Montana K, Petrash JM, Ammar DA. Impact of Subunit Composition on the Uptake of α-Crystallin by Lens and Retina. Plos One. 10: e0137659. PMID 26355842 DOI: 10.1371/Journal.Pone.0137659 |
0.369 |
|
| 2015 |
Chang KC, Petrash JM. Aldose Reductase Mediates Transforming Growth Factor β2 (TGF-β2)-Induced Migration and Epithelial-To-Mesenchymal Transition of Lens-Derived Epithelial Cells. Investigative Ophthalmology & Visual Science. 56: 4198-210. PMID 26132779 DOI: 10.1167/iovs.15-16557 |
0.65 |
|
| 2015 |
Snow A, Shieh B, Chang KC, Pal A, Lenhart P, Ammar D, Ruzycki P, Palla S, Reddy GB, Petrash JM. Aldose reductase expression as a risk factor for cataract. Chemico-Biological Interactions. 234: 247-53. PMID 25541468 DOI: 10.1016/J.Cbi.2014.12.017 |
0.703 |
|
| 2015 |
Chang KC, Snow A, LaBarbera DV, Petrash JM. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells. Chemico-Biological Interactions. 234: 254-60. PMID 25451566 DOI: 10.1016/J.Cbi.2014.10.007 |
0.713 |
|
| 2014 |
Lanaspa MA, Ishimoto T, Cicerchi C, Tamura Y, Roncal-Jimenez CA, Chen W, Tanabe K, Andres-Hernando A, Orlicky DJ, Finol E, Inaba S, Li N, Rivard CJ, Kosugi T, Sanchez-Lozada LG, ... Petrash JM, et al. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. Journal of the American Society of Nephrology : Jasn. 25: 2526-38. PMID 24876114 DOI: 10.1681/Asn.2013080901 |
0.336 |
|
| 2014 |
Chang KC, Ponder J, Labarbera DV, Petrash JM. Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia. Investigative Ophthalmology & Visual Science. 55: 2853-61. PMID 24677107 DOI: 10.1167/Iovs.13-13487 |
0.699 |
|
| 2014 |
Li L, Chang KC, Zhou Y, Shieh B, Ponder J, Abraham AD, Ali H, Snow A, Petrash JM, LaBarbera DV. Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. Journal of Medicinal Chemistry. 57: 71-7. PMID 24341381 DOI: 10.1021/Jm401311D |
0.677 |
|
| 2014 |
Christopher KL, Pedler MG, Shieh B, Ammar DA, Petrash JM, Mueller NH. Alpha-crystallin-mediated protection of lens cells against heat and oxidative stress-induced cell death. Biochimica Et Biophysica Acta. 1843: 309-15. PMID 24275510 DOI: 10.1016/J.Bbamcr.2013.11.010 |
0.348 |
|
| 2014 |
Lee CA, Li G, Patel MD, Petrash JM, Benetz BA, Veenstra A, Amengual J, von Lintig J, Burant CJ, Tang J, Kern TS. Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Investigative Ophthalmology & Visual Science. 55: 2904-10. PMID 23920367 DOI: 10.1167/Iovs.13-11659 |
0.364 |
|
| 2014 |
Akileshwari C, Raghu G, Muthenna P, Mueller NH, Suryanaryana P, Petrash JM, Reddy GB. Bioflavonoid ellagic acid inhibits aldose reductase: Implications for prevention of diabetic complications Journal of Functional Foods. 6: 374-383. DOI: 10.1016/J.Jff.2013.11.004 |
0.384 |
|
| 2014 |
Chang KC, Snow A, LaBarbera DV, Petrash JM. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells Chemico-Biological Interactions. DOI: 10.1016/j.cbi.2014.10.007 |
0.651 |
|
| 2013 |
Petrash JM. Aging and age-related diseases of the ocular lens and vitreous body. Investigative Ophthalmology & Visual Science. 54: ORSF54-9. PMID 24335070 DOI: 10.1167/Iovs.13-12940 |
0.316 |
|
| 2013 |
Tang J, Du Y, Petrash JM, Sheibani N, Kern TS. Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation. Plos One. 8: e62081. PMID 23614016 DOI: 10.1371/Journal.Pone.0062081 |
0.42 |
|
| 2013 |
Énzsöly A, Markó K, Tábi T, Szökő É, Zelkó R, Tóth M, Petrash JM, Mátyus P, Németh J. Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 969-75. PMID 23397320 DOI: 10.1007/S00702-013-0986-0 |
0.301 |
|
| 2013 |
Chang KC, Laffin B, Ponder J, Enzsöly A, Németh J, LaBarbera DV, Petrash JM. Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues. Chemico-Biological Interactions. 202: 283-7. PMID 23247009 DOI: 10.1016/J.Cbi.2012.12.001 |
0.677 |
|
| 2012 |
Rao VR, Muthenna P, Shankaraiah G, Akileshwari C, Babu KH, Suresh G, Babu KS, Chandra Kumar RS, Prasad KR, Yadav PA, Petrash JM, Reddy GB, Rao JM. Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs). European Journal of Medicinal Chemistry. 57: 344-61. PMID 23124161 DOI: 10.1016/J.Ejmech.2012.09.014 |
0.326 |
|
| 2012 |
Samuels IS, Lee CA, Petrash JM, Peachey NS, Kern TS. Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease. Visual Neuroscience. 29: 267-74. PMID 23101909 DOI: 10.1017/S0952523812000326 |
0.394 |
|
| 2012 |
Akileshwari C, Muthenna P, Nastasijević B, Joksić G, Petrash JM, Reddy GB. Inhibition of aldose reductase by Gentiana lutea extracts. Experimental Diabetes Research. 2012: 147965. PMID 22844269 DOI: 10.1155/2012/147965 |
0.323 |
|
| 2012 |
Puppala M, Ponder J, Suryanarayana P, Reddy GB, Petrash JM, LaBarbera DV. The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. Plos One. 7: e31399. PMID 22485126 DOI: 10.1371/Journal.Pone.0031399 |
0.393 |
|
| 2011 |
Validandi V, Reddy VS, Srinivas PN, Mueller NH, Bhagyalaxmi SG, Padma T, Petrash JM, Reddy GB. Temperature-dependent structural and functional properties of a mutant (F71L) αA-crystallin: molecular basis for early onset of age-related cataract. Febs Letters. 585: 3884-9. PMID 22085609 DOI: 10.1016/J.Febslet.2011.10.049 |
0.314 |
|
| 2011 |
Zablocki GJ, Ruzycki PA, Overturf MA, Palla S, Reddy GB, Petrash JM. Aldose reductase-mediated induction of epithelium-to-mesenchymal transition (EMT) in lens. Chemico-Biological Interactions. 191: 351-6. PMID 21329682 DOI: 10.1016/J.Cbi.2011.02.005 |
0.395 |
|
| 2011 |
Ruiz FX, Moro A, Gallego O, Ardèvol A, Rovira C, Petrash JM, Parés X, Farrés J. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde. Chemico-Biological Interactions. 191: 199-205. PMID 21329680 DOI: 10.1016/J.Cbi.2011.02.007 |
0.346 |
|
| 2011 |
Salabei JK, Li XP, Petrash JM, Bhatnagar A, Barski OA. Functional expression of novel human and murine AKR1B genes. Chemico-Biological Interactions. 191: 177-84. PMID 21276782 DOI: 10.1016/J.Cbi.2011.01.020 |
0.317 |
|
| 2010 |
Hegde KR, Kowluru RA, Mohr S, Nagaraj RH, Petrash JM. New horizons in research on diabetic complications of the eye: special emphasis on diabetic cataracts and retinopathy. Journal of Ophthalmology. 2010: 979040. PMID 21049002 DOI: 10.1155/2010/979040 |
0.404 |
|
| 2010 |
Srinivas P, Narahari A, Petrash JM, Swamy MJ, Reddy GB. Importance of eye lens α-crystallin heteropolymer with 3:1 αA to αB ratio: stability, aggregation, and modifications. Iubmb Life. 62: 693-702. PMID 20836128 DOI: 10.1002/Iub.373 |
0.328 |
|
| 2010 |
Huang SP, Palla S, Ruzycki P, Varma RA, Harter T, Reddy GB, Petrash JM. Aldo-keto reductases in the eye. Journal of Ophthalmology. 2010: 521204. PMID 20628518 DOI: 10.1155/2010/521204 |
0.425 |
|
| 2009 |
Muthenna P, Suryanarayana P, Gunda SK, Petrash JM, Reddy GB. Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance. Febs Letters. 583: 3637-42. PMID 19850041 DOI: 10.1016/J.Febslet.2009.10.042 |
0.399 |
|
| 2009 |
Bhagyalaxmi SG, Srinivas P, Barton KA, Kumar KR, Vidyavathi M, Petrash JM, Bhanuprakash Reddy G, Padma T. A novel mutation (F71L) in alphaA-crystallin with defective chaperone-like function associated with age-related cataract. Biochimica Et Biophysica Acta. 1792: 974-81. PMID 19595763 DOI: 10.1016/J.Bbadis.2009.06.011 |
0.671 |
|
| 2009 |
Shi Y, Barton K, De Maria A, Petrash JM, Shiels A, Bassnett S. The stratified syncytium of the vertebrate lens. Journal of Cell Science. 122: 1607-15. PMID 19401333 DOI: 10.1242/Jcs.045203 |
0.692 |
|
| 2009 |
Barton KA, Hsu CD, Petrash JM. Interactions between small heat shock protein alpha-crystallin and galectin-related interfiber protein (GRIFIN) in the ocular lens. Biochemistry. 48: 3956-66. PMID 19296714 DOI: 10.1021/Bi802203A |
0.681 |
|
| 2009 |
Tammali R, Reddy AB, Ramana KV, Petrash JM, Srivastava SK. Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation. Carcinogenesis. 30: 799-807. PMID 19028703 DOI: 10.1093/Carcin/Bgn246 |
0.353 |
|
| 2008 |
Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pacific Journal of Clinical Nutrition. 17: 558-65. PMID 19114390 DOI: 10.6133/Apjcn.2008.17.4.03 |
0.375 |
|
| 2007 |
Barton KA, Shui YB, Petrash JM, Beebe DC. Comment on: the Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmologica Scandinavica. 85: 339-40. PMID 17362364 DOI: 10.1111/J.1600-0420.2007.00902.X |
0.661 |
|
| 2007 |
Estey T, Cantore M, Weston PA, Carpenter JF, Petrash JM, Vasiliou V. Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1. The Journal of Biological Chemistry. 282: 4382-92. PMID 17158879 DOI: 10.1074/Jbc.M607546200 |
0.337 |
|
| 2007 |
Chang Q, Griest TA, Harter TM, Petrash JM. Functional studies of aldo-keto reductases in Saccharomyces cerevisiae. Biochimica Et Biophysica Acta. 1773: 321-9. PMID 17140678 DOI: 10.1016/J.Bbamcr.2006.10.009 |
0.309 |
|
| 2006 |
Singh R, White MA, Ramana KV, Petrash JM, Watowich SJ, Bhatnagar A, Srivastava SK. Structure of a glutathione conjugate bound to the active site of aldose reductase. Proteins. 64: 101-10. PMID 16639747 DOI: 10.1002/Prot.20988 |
0.346 |
|
| 2002 |
Cobb BA, Petrash JM. Factors influencing alpha-crystallin association with phospholipid vesicles. Molecular Vision. 8: 85-93. PMID 11951084 |
0.583 |
|
| 2002 |
Cobb BA, Petrash JM. alpha-Crystallin chaperone-like activity and membrane binding in age-related cataracts. Biochemistry. 41: 483-90. PMID 11781086 DOI: 10.1021/Bi0112457 |
0.631 |
|
| 2001 |
Costantino L, Del Corso A, Rastelli G, Petrash JM, Mura U. 7-Hydroxy-2-substituted-4-H-1-benzopyran-4-one derivatives as aldose reductase inhibitors: a SAR study. European Journal of Medicinal Chemistry. 36: 697-703. PMID 11672879 DOI: 10.1016/S0223-5234(01)01272-7 |
0.304 |
|
| 2001 |
Petrash JM, Murthy BS, Young M, Morris K, Rikimaru L, Griest TA, Harter T. Functional genomic studies of aldo-keto reductases. Chemico-Biological Interactions. 130: 673-83. PMID 11306085 DOI: 10.1016/S0009-2797(00)00258-1 |
0.36 |
|
| 2001 |
Ramana KV, Dixit BL, Srivastava S, Bhatnagar A, Balendiran GK, Watowich SJ, Petrash JM, Srivastava SK. Characterization of the glutathione binding site of aldose reductase. Chemico-Biological Interactions. 130: 537-48. PMID 11306073 DOI: 10.1016/S0009-2797(00)00297-0 |
0.301 |
|
| 2000 |
Cobb BA, Petrash JM. Structural and functional changes in the alpha A-crystallin R116C mutant in hereditary cataracts. Biochemistry. 39: 15791-8. PMID 11123904 DOI: 10.1021/bi001453j |
0.614 |
|
| 2000 |
Dixit BL, Balendiran GK, Watowich SJ, Srivastava S, Ramana KV, Petrash JM, Bhatnagar A, Srivastava SK. Kinetic and structural characterization of the glutathione-binding site of aldose reductase. The Journal of Biological Chemistry. 275: 21587-95. PMID 10764810 DOI: 10.1074/Jbc.M909235199 |
0.34 |
|
| 2000 |
Cobb BA, Petrash JM. Characterization of alpha-crystallin-plasma membrane binding. The Journal of Biological Chemistry. 275: 6664-72. PMID 10692476 DOI: 10.1074/Jbc.275.9.6664 |
0.615 |
|
| 1999 |
Srivastava S, Watowich SJ, Petrash JM, Srivastava SK, Bhatnagar A. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry. 38: 42-54. PMID 9890881 DOI: 10.1021/Bi981794L |
0.338 |
|
| 1998 |
Srivastava S, Harter TM, Chandra A, Bhatnagar A, Srivastava SK, Petrash JM. Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry. 37: 12909-17. PMID 9737870 DOI: 10.1021/Bi9804333 |
0.353 |
|
| 1997 |
Chandra A, Srivastava S, Petrash JM, Bhatnagar A, Srivastava SK. Modification of aldose reductase by S-nitrosoglutathione. Biochemistry. 36: 15801-9. PMID 9398310 DOI: 10.1021/Bi9714722 |
0.303 |
|
| 1997 |
Chandra A, Srivastava S, Petrash JM, Bhatnagar A, Srivastava SK. Active site modification of aldose reductase by nitric oxide donors. Biochimica Et Biophysica Acta. 1341: 217-22. PMID 9357961 DOI: 10.1016/S0167-4838(97)00084-8 |
0.326 |
|
| 1997 |
Petrash JM, Harter TM, Murdock GL. A potential role for aldose reductase in steroid metabolism. Advances in Experimental Medicine and Biology. 414: 465-73. PMID 9059652 DOI: 10.1007/978-1-4615-5871-2_53 |
0.336 |
|
| 1997 |
Wilson DK, Nakano T, Petrash JM, Quiocho FA. Structural studies of aldo-keto reductase inhibition. Advances in Experimental Medicine and Biology. 414: 435-42. PMID 9059648 DOI: 10.1007/978-1-4615-5871-2_49 |
0.352 |
|
| 1996 |
Das KP, Petrash JM, Surewicz WK. Conformational properties of substrate proteins bound to a molecular chaperone alpha-crystallin. The Journal of Biological Chemistry. 271: 10449-52. PMID 8631839 DOI: 10.1074/Jbc.271.18.10449 |
0.321 |
|
| 1995 |
Cook PN, Ward WH, Petrash JM, Mirrlees DJ, Sennitt CM, Carey F, Preston J, Brittain DR, Tuffin DP, Howe R. Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase. Biochemical Pharmacology. 49: 1043-9. PMID 7748183 DOI: 10.1016/0006-2952(95)98499-Y |
0.31 |
|
| 1993 |
Petrash JM, Harter T, Tarle I, Borhani D. Kinetic alteration of human aldose reductase by mutagenesis of cysteine residues. Advances in Experimental Medicine and Biology. 328: 289-300. PMID 8493906 DOI: 10.1007/978-1-4615-2904-0_31 |
0.362 |
|
| 1993 |
Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 42: 221-32. PMID 7678825 DOI: 10.2337/Diab.42.2.221 |
0.368 |
|
| 1991 |
Petrash JM, DeLucas LJ, Bowling E, Egen N. Resolving isoforms of aldose reductase by preparative isoelectric focusing in the Rotofor. Electrophoresis. 12: 84-90. PMID 1904814 DOI: 10.1002/Elps.1150120116 |
0.304 |
|
| 1985 |
Srivastava SK, Das B, Hair GA, Gracy RW, Awasthi S, Ansari NH, Petrash JM. Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties. Biochimica Et Biophysica Acta. 840: 334-43. PMID 3924115 DOI: 10.1016/0304-4165(85)90213-2 |
0.328 |
|
| Show low-probability matches. |